Updates are available Correction dated 2024-01-25
Click to view Correction: https://doi.org/10.1038/s41587-024-02142-1
-
Authors
Fiumara, Martina https://orcid.org/0009-0007-5934-9273
Ferrari, Samuele https://orcid.org/0000-0003-1122-1231
Omer-Javed, Attya
Beretta, Stefano https://orcid.org/0000-0003-4375-004X
Albano, Luisa https://orcid.org/0000-0002-0013-4741
Canarutto, Daniele https://orcid.org/0000-0001-6999-8479
Varesi, Angelica
Gaddoni, Chiara
Brombin, Chiara
Cugnata, Federica
Zonari, Erika
Naldini, Matteo Maria https://orcid.org/0000-0002-9542-2884
Barcella, Matteo
Gentner, Bernhard
Merelli, Ivan
Naldini, Luigi https://orcid.org/0000-0002-7835-527X
- License Information
-
More Information
Article History
Received: 21 November 2022
Accepted: 26 July 2023
First Online: 7 September 2023
Change Date: 25 January 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41587-024-02142-1
Competing interests
: L.N. is inventor of patents on applications of HSPC gene editing and transplantation, owned and managed by the San Raffaele Scientific Institute and the Telethon Foundation, including on improved gene editing filed together with M.F., S.F., A.O.-J and D.C. L.N. is founder of and quota holder and consultant for GeneSpire and Epsilen Bio/Chroma Medicine. All other authors have no competing interests.
